Indrani Lall Franchini is CCO & VP at ALEXION PHARMACEUTICALS, INC. (ALXN). They have made 9 open-market trades across 2 companies since 2018, most recently 2025-01-02.
CIK 0001708764
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALNY | SELL | 2024-02-28 | 2024-02-29 | $155.30 | $51K | -2.8% | +1.6% | -2.6% |
| ALNY | SELL | 2024-02-02 | 2024-02-05 | $170.87 | $498K | -13.6% | -12.3% | -11.4% |
| ALNY | SELL | 2023-04-06 | 2023-04-10 | $210.00 | $735K | -1.3% | +2.7% | -2.7% |
| ALNY | SELL | 2023-02-02 | 2023-02-03 | $226.05 | $739K | -3.7% | -13.5% | -11.0% |
| ALXN | SELL | 2020-06-08 | 2020-06-09 | $114.66 | $1.4M | +2.9% | -6.5% | -6.7% |
| ALXN | SELL | 2019-07-01 | 2019-07-02 | $132.78 | $598K | -8.4% | -14.4% | -27.0% |
| ALXN | SELL | 2018-11-28 | 2018-11-30 | $118.13 | $615K | -8.7% | -21.0% | +9.8% |
| ALXN | SELL | 2018-06-08 | 2018-06-12 | $118.53 | $348K | +8.5% | +14.2% | +0.2% |
| ALXN | SELL | 2018-02-08 | 2018-02-08 | $116.31 | $339K | +7.4% | +16.5% | +7.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.